DV
Dividend Vision

MMED — MiniMed Group, Inc.

MiniMed Group, Inc. (MMED)

Total return is 0.7% over the past 0.4 years, 13.9 points behind SPY at 14.6%.

MiniMed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for diabetes management, including insulin pumps, continuous glucose monitors, automated insulin delivery systems, and related software platforms like CareLink. The company serves people with Type 1 diabetes and insulin-dependent Type 2 diabetes patients, operating as a subsidiary of Medtronic plc. Distribution information for this security is not currently available.

MMED key facts

Asset type
Stock
Asset class
Equity
Inception date
03/05/2026
Distribution frequency
None
Last close
$20.15
Market cap
$5,658,983,424
Average volume
1069200.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.31